MVMD provides our global nutraceutical, vaccine, and pharmaceutical partners with unprecedented product and market advantages. The Company’s patented Quicksome™ desiccation technology and Quicksol™ solubilization technology enable existing approved vaccines, drugs and nutraceuticals to be delivered more effectively. MVMD does game changing work across dose sparing, cold chain, needle free delivery and solubilization that enable the delivery of complex molecules into the body faster, with greater impact, efficiency and accuracy. CSE: MVMD.CN OTC: MVMDF